Sign in
CompletedNo phase

tTIS Targeted of the Striatum as an Intervention for MUD Patients

Key facts

Who runs it
Shanghai Mental Health Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
53 people enrolled
Started
26 Mar 2026
Ended
1 Aug 2026
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Temporal Interference Stimulation
  • Shame
Record updated
2 September 2026

Who can take part

Age
18 years to 55 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Individuals aged between 18 and 55 years, irrespective of gender, having completed a minimum of 6 years of education and capable of effectively cooperating in questionnaire evaluations
  • Meet the diagnostic criteria set forth by the DSM-V concerning the amphetamine-type substance addiction
  • A history of utilizing amphetamine-type substances for a duration not less than one year, with a frequency of use being at least once per week
  • Consent to actively cooperate in the completion of subsequent follow-up assessments

Who cannot take part

  • Severe cognitive functional impairments manifested through a history of head trauma, cerebrovascular diseases, epilepsy, etc., or usage of cognitive enhancement drugs in the past 6 months; an intellectual disability with an IQ score less than 70
  • A diagnosis of schizophrenia or other severe mental illnesses as per the DSM-5 criteria
  • Severe organic diseases that might compromise study participation
  • Contraindications to cTBS, such as a history of epileptic seizures or the presence of metallic implants in proximity to the head
  • Abuse or dependence on other psychoactive substances (excluding nicotine) within the past 5 years

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Targeted temporal interference stimulation (tTIS) of the caudate nucleus can modulate the abnormal electrophysiological activity in individuals with methamphetamine use disorder (MUD), thereby improving their impaired reward-learning behaviors and reducing drug craving.

The 2 groups in the trial

  • Temporal Interference Stimulation GroupTreatment being tested

    The first pair of electrodes continuously delivers a current at a frequency of f1 = 2 kHz, while the second pair delivers a current at f2 = 2.130 kHz. Based on the principle of temporal interference, an alternating electric field at a frequency of f1 - f2 = 130 Hz is generated in the target region.

    Treatment: Temporal Interference Stimulation

  • Control GroupSham treatment, for comparison

    The stimulation parameters-including frequency, current intensity, and duration-are identical to those in the active group. Sham stimulation used the same montage and ramp procedures but delivered stimulation for only 1 minute per session before the stimulator was turned off.

    Treatment: Shame

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Transcranial Temporal Interference Stimulation Targeted of the Striatum as an Intervention for Methamphetamine Use Disorder Patients
Record updated
2 September 2026